论文信息 - Subcutaneously Administered Efalizumab (Anti-CD11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis - 字舞流文

Subcutaneously Administered Efalizumab (Anti-CD11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis

A. Gottlieb | B. Miller | P. Walicke | M. Garovoy | N. Lowe | C. McCall | W. Dummer | M. Ling | R. Bauer | M. White | W. Shapiro | T. Rist | A. Magee | Charles P Hudson | R. Bright | Anna Magee